Eledon Pharmaceuticals, Inc. Annual Return On Equity in % from 2015 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Eledon Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from 2015 to 2023.
  • Eledon Pharmaceuticals, Inc. Return On Equity for the quarter ending June 30, 2024 was -2.22K %, a 1211% decline year-over-year.
  • Eledon Pharmaceuticals, Inc. annual Return On Equity for 2023 was -289 %, a 336% decline from 2022.
  • Eledon Pharmaceuticals, Inc. annual Return On Equity for 2022 was -66.3 %, a 235% decline from 2021.
  • Eledon Pharmaceuticals, Inc. annual Return On Equity for 2021 was -19.8 %, a 49.4% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -289 -223 -336% Jan 1, 2023 Dec 31, 2023
2022 -66.3 -46.5 -235% Jan 1, 2022 Dec 31, 2022
2021 -19.8 +19.3 +49.4% Jan 1, 2021 Dec 31, 2021
2020 -39.1 +92.1 +70.2% Jan 1, 2020 Dec 31, 2020
2019 -131 -59.7 -83.5% Jan 1, 2019 Dec 31, 2019
2018 -71.6 -11.2 -18.5% Jan 1, 2018 Dec 31, 2018
2017 -60.4 -41.2 -215% Jan 1, 2017 Dec 31, 2017
2016 -19.2 +53.4 +73.6% Jan 1, 2016 Dec 31, 2016
2015 -72.6 Jan 1, 2015 Dec 31, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.